NASDAQ:CBLL CeriBell (CBLL) Stock Price, News & Analysis $18.71 +0.01 (+0.05%) As of 03:12 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About CeriBell Stock (NASDAQ:CBLL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CeriBell alerts:Sign Up Key Stats Today's Range$18.49▼$18.9350-Day Range$16.30▼$21.3352-Week Range$10.85▼$24.33Volume97,698 shsAverage Volume318,581 shsMarket Capitalization$709.86 millionP/E RatioN/ADividend YieldN/APrice Target$22.20Consensus RatingModerate Buy Company Overview CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention. The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows. CeriBell devices typically feature automated test protocols, digital signal processing and connectivity options for integration with electronic health record systems. These diagnostic platforms are engineered to meet regulatory requirements in multiple jurisdictions and are complemented by service contracts and technical support offerings. CeriBell has developed a global presence through direct sales and distribution partnerships across North America, Europe and select international markets. By collaborating with healthcare providers, clinical laboratories and research institutions, the company focuses on refining screening protocols, delivering training resources and expanding access to early hearing assessment solutions. CeriBell’s commitment to innovation and clinical validation underpins its mission to reduce the incidence of undiagnosed hearing loss in newborns and support positive developmental outcomes in pediatric populations.AI Generated. May Contain Errors. Read More CeriBell Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScoreCBLL MarketRank™: CeriBell scored higher than 40% of companies evaluated by MarketBeat, and ranked 689th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingCeriBell has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 1 strong buy rating, 4 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialCeriBell has a consensus price target of $22.20, representing about 18.3% upside from its current price of $18.76.Amount of Analyst CoverageCeriBell has only been the subject of 2 research reports in the past 90 days.Read more about CeriBell's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for CeriBell are expected to grow in the coming year, from ($1.69) to ($1.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CeriBell is -11.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CeriBell is -11.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCeriBell has a P/B Ratio of 5.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about CeriBell's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.47% of the float of CeriBell has been sold short.Short Interest Ratio / Days to CoverCeriBell has a short interest ratio ("days to cover") of 4.88.Change versus previous monthShort interest in CeriBell has recently increased by 4.12%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCeriBell does not currently pay a dividend.Dividend GrowthCeriBell does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.15 News SentimentCeriBell has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for CeriBell this week, compared to 4 articles on an average week.MarketBeat Follows1 people have added CeriBell to their MarketBeat watchlist in the last 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, CeriBell insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,086,400.00 in company stock.Percentage Held by Insiders20.10% of the stock of CeriBell is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsCeriBell has minimal institutional ownership at this time.Read more about CeriBell's insider trading history. Receive CBLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CeriBell and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CBLL Stock News HeadlinesInsider Selling: CeriBell (NASDAQ:CBLL) VP Sells 862 Shares of StockMay 27 at 5:28 AM | insidertrades.comCeriBell, Inc. (NASDAQ:CBLL) Receives $22.20 Consensus PT from AnalystsMay 21, 2026 | americanbankingnews.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.May 28 at 1:00 AM | Porter & Company (Ad)Ceribell to Participate in the William Blair 46th Annual Growth Stock ConferenceMay 20, 2026 | globenewswire.comBank of America Securities Remains a Buy on Ceribell, Inc. (CBLL)May 19, 2026 | theglobeandmail.comCeriBell sees 'early innings' growth as hospital accounts and usage hit recordsMay 15, 2026 | msn.comCeribell Reports First Quarter 2026 Financial ResultsMay 11, 2026 | markets.businessinsider.comInsider Selling: CeriBell (NASDAQ:CBLL) CEO Sells 39,000 Shares of StockMay 8, 2026 | insidertrades.comSee More Headlines CBLL Stock Analysis - Frequently Asked Questions How have CBLL shares performed this year? CeriBell's stock was trading at $21.93 on January 1st, 2026. Since then, CBLL stock has decreased by 14.5% and is now trading at $18.76. How were CeriBell's earnings last quarter? CeriBell, Inc. (NASDAQ:CBLL) issued its quarterly earnings results on Monday, May, 11th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.39) by $0.13. The firm earned $26.49 million during the quarter, compared to the consensus estimate of $26.09 million. CeriBell had a negative trailing twelve-month return on equity of 38.19% and a negative net margin of 63.51%. Read the conference call transcript. When did CeriBell IPO? CeriBell (CBLL) raised $159 million in an IPO on Friday, October 11th 2024. The company issued 10,606,060 shares at $14.00-$16.00 per share. Who are CeriBell's major shareholders? CeriBell's top institutional shareholders include KCM Capital Inc (3.69%), Bank of New York Mellon Corp (3.06%), Redmile Group LLC (1.02%) and Peregrine Capital Management LLC (0.92%). Insiders that own company stock include Xingjuan Chao, Josef Parvizi, Raymond Woo, Scott Blumberg, Joseph S Manni, David Foehr, Rebecca B Robertson and William W Burke. View institutional ownership trends. How do I buy shares of CeriBell? Shares of CBLL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/11/2026Today5/28/202646th Annual William Blair Growth Stock Conference6/03/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 8 days, CBLL's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:CBLL Previous SymbolNASDAQ:CBLL CIK1861107 WebN/A Phone(800) 436-0826FaxN/AEmployeesN/AYear Founded2014Price Target and Rating Average Price Target for CeriBell$22.20 High Price Target$30.00 Low Price Target$17.00 Potential Upside/Downside+18.7%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($1.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$53.41 million Net Margins-63.51% Pretax Margin-63.51% Return on Equity-38.19% Return on Assets-30.92% Debt Debt-to-Equity Ratio0.14 Current Ratio10.44 Quick Ratio10.01 Sales & Book Value Annual Sales$89.06 million Price / Sales7.97 Cash FlowN/A Price / Cash FlowN/A Book Value$3.71 per share Price / Book5.04Miscellaneous Outstanding Shares37,940,000Free Float30,316,000Market Cap$709.86 million OptionableN/A Beta0.99 Social Links The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:CBLL) was last updated on 5/28/2026 by MarketBeat.com Staff. From Our PartnersThe math on the SpaceX IPO is brokenSpaceX is expected to go public at a $1.75 trillion valuation. For investors to see a 10x return, the company ...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThey're not telling you how bad this could getValuations are stretched to levels seen only a handful of times in the last hundred years — yet most retiremen...Parkview Capital Group | SponsoredWhen SpaceX goes public your retirement pays the priceWhen SpaceX files its S-1, institutions will liquidate holdings, rebalance portfolios, and free up capital for...Reagan Gold Group | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredMassive Data Leak Exposes 512,000-Line Code That Could Change Society Forever"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...Chaikin Analytics | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
